Premium
Functional central nervous system myelin repair in an adult mouse model of demyelination caused by proteolipid protein overexpression
Author(s) -
EspinosaJeffrey A.,
Hitoshi S.,
Zhao P.,
Awosika O.,
Agbo C.,
Olaniyan E.,
Garcia J.,
Valera R.,
Thomassian A.,
ChangWei R.,
Yamaguchi M.,
de Vellis J.,
Ikenaka K.
Publication year - 2010
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.22334
Subject(s) - remyelination , hindlimb , central nervous system , paralysis , genetically modified mouse , transgene , myelin , biology , neuroscience , proteolipid protein 1 , myelin basic protein , medicine , anatomy , gene , genetics , surgery
Two types of interventions to remyelinate the adult demyelinated central nervous system were investigated in heterozygous transgenic mice overexpressing the proteolipid protein gene. 1) A cocktail of trophic factors, “TS1,” was directed toward the activation of the endogenous pool of neural progenitors to increase the number of myelinating oligodendrocytes (OL) in the brain. 2) A combinatorial approach in which OL progenitors were coinjected with TS1 into the corpus callosum of wild‐type and He4e transgenic mice that displayed hindlimb paralysis. The levels of locomotor ability in these mice were evaluated after a single treatment. The data showed that a single administration of either one of the interventions had similar therapeutic effects, alleviating the symptoms of demyelination and leading to the recovery of hindlimb function. Histological and immunofluorescent examination of brain sections showed extensive remyelination that was sufficient to reverse hindlimb paralysis in transgenic mice. When the interventions were administered prior to hindlimb paralysis, He4e mice were able to walk up to 1 year of age without paralysis. © 2010 Wiley‐Liss, Inc.